Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

NAP1L4 Inhibitors

NAP1L4 inhibitors are a class of chemical compounds that specifically target and inhibit the NAP1L4 (Nucleosome Assembly Protein 1-Like 4) protein, which plays a critical role in chromatin dynamics and nucleosome assembly. NAP1L4 is part of the NAP family of proteins, known for their involvement in the regulation of histone transport and the assembly of nucleosomes, which are fundamental units of chromatin structure. NAP1L4 is thought to function as a histone chaperone, facilitating the deposition of histones onto DNA, thereby contributing to chromatin remodeling and maintaining proper chromatin structure. By inhibiting NAP1L4, researchers can explore how disruption of histone handling and nucleosome assembly affects gene regulation, chromatin organization, and overall genomic stability.

The mechanism of NAP1L4 inhibitors generally involves blocking the interaction of NAP1L4 with histones or interfering with its ability to assist in nucleosome assembly. These inhibitors might bind to the protein's histone-binding domain, preventing it from interacting with histones, or they might alter the protein's structure through allosteric modulation, rendering it unable to perform its chaperone function. Structurally, NAP1L4 inhibitors may resemble the natural substrates of the protein or contain specific groups that interact with key residues involved in histone binding. The use of these inhibitors allows researchers to study the effects of impaired nucleosome assembly on chromatin structure, transcription regulation, and DNA repair mechanisms. Understanding the role of NAP1L4 and the consequences of its inhibition provides valuable insights into the broader processes that govern chromatin dynamics and how these processes influence gene expression and cellular functions.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A could downregulate NAP1L4 by inhibiting histone deacetylase, which may result in a condensed chromatin state less conducive to transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting DNA methyltransferase, 5-Azacytidine could lead to the hypomethylation of gene promoters, potentially decreasing the transcription of NAP1L4.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

5-Aza-2′-Deoxycytidine may reduce the methylation levels of the NAP1L4 gene promoter, thereby decreasing its transcriptional activity and subsequent protein expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid could decrease NAP1L4 expression by inhibiting histone deacetylases, leading to the accumulation of acetylated histones and altered gene expression profiles.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin may inhibit the mTOR signaling pathway, which could result in reduced protein synthesis, including the downregulation of NAP1L4.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol may lead to the downregulation of NAP1L4 by enhancing the deacetylation of histones through activation of sirtuin proteins, altering gene expression.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin could inhibit the transcription factor NF-kB, which may be involved in the transcriptional activation of NAP1L4, leading to its decreased expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic Acid might downregulate NAP1L4 by binding to retinoic acid receptors that interact with promoter regions of genes, altering transcriptional activity.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate may lead to a decrease in NAP1L4 expression by disrupting folate metabolism, thus affecting the availability of nucleotides for DNA and RNA synthesis.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Hydroxyurea could inhibit ribonucleotide reductase, leading to a reduction in deoxyribonucleotide pools, which could result in decreased NAP1L4 expression due to limited DNA synthesis.